SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 7, 2012
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
Registrants telephone number, including area code: 011-59-99-465-8525
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On November 7, 2012, Luigi Ferrari, the Companys President, Global Orthopedics Business Unit, notified the Company of his voluntary resignation of employment from the Company. Mr. Ferrari informed the Company he has accepted the position of Chief Executive Officer of Limacorporate S.p.a. in Udine, Italy. Mr. Ferraris resignation will be effective as of a date to be mutually agreed by Mr. Ferrari and the Company, at which time Robert S. Vaters, the Companys President and Chief Executive Officer, will assume Mr. Ferraris operational responsibilities.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 13, 2012